 |
Partners' Directory |
| Home Search Join the Partnership Login | |
| Contact | General | Specializations in Countries | Contribution to the Global Plan | Declaration |
View this partner's profile
Organization Contact Information | |
| Name: | Jhpiego, an affiliate of Johns Hopkins University |
| Street 1: | 1615 Thames St. |
| Street 2: | |
| City: | Baltimore |
| Province: | Maryland |
| Post Code: | 21231 |
| Country: | United States of America |
| Phone: | +1 410 537 1800 |
| Email: | info@jhpiego.net |
| Web Site: | http://www.jhpiego.org |
|
|
||||||||||||||||||||||||||||
General Information | |
| Board Constituency: | Developed Country NGO |
| Organization Type - Primary: | Non-Governmental Organization |
| Organization Type - Secondary: | Other Non-Governmental Organization (NGO) |
| Is your organization legally registered in your country: | Yes |
| Organization Reach: | International |
| Organization Description: | |
| Jhpiego is an international, non-profit affiliate of Johns Hopkins University. Jhpiego enhances the health and saves the lives of women and families in limited-resource settings. For nearly four decades, we have put evidence-based health innovations into everyday practice to overcome barriers to high-quality health care services for the world's most vulnerable populations. From our origins as technical experts in reproductive, maternal and child health, Jhpiego has grown to embrace new challenges, including HIV/AIDS, malaria and cervical cancer prevention—reflecting the increasing interconnectedness of global health. Our work in HIV counseling and testing and HIV clinical care has involved us in TB/HIV integration. We also work on infection prevention and control in healthcare settings, including prevention of bloodborne and respiratory infections. | |
| Total number of staff in your organization: | 100 + |
| Number of full-time staff who are directly involved with TB: | 6 - 10 |
| Number of part-time staff who are directly involved with TB: | 1 - 5 |
| Number of volunteers who are directly involved with TB: | 0 |
| What is your organization's annual budget (USD) dedicated to TB? | Unable to disclose amount |
| How did you hear about the Stop TB Partnership: | Other partners |
| Why do you wish join the Stop TB Partnership: | Other (please explain) |
| Are you a member of a Stop TB national partnership: | No |
| Are you in contact with your national TB programme: | Yes |
| Please tell us how your organization is contributing to your country's national TB control plan: | |
| Jhpiego currently works in over 50 countries, supporting TB prevention, case finding, care, treatment, and support in several. Depending on country of implementation, Jhpiego supports the national TB control plan in a myriad of ways including assistance with development and implementation of guidelines (TB infection control, TB/HIV, MDR-TB, etc.), development and delivery of training materials, raising community & health care provider awareness of importance of TB (integrative approach), as well as others. | |
Geographical Reach | |
| Which country is your headquarters located in: | United States of America |
| Which WHO region is the main focus of your work: | African |
| Which countries do you do operate in: (This includes countries you are conducting activities in) |
Afghanistan Angola Azerbaijan Bangladesh Benin Bolivia Botswana Burkina Faso Cote d'Ivoire Democratic Republic of the Congo Democratic Republic of Timor-Leste Dominican Republic Equatorial Guinea Ethiopia Ghana Guatemala Guinea Guyana Haiti Honduras India Indonesia Kenya Lesotho Liberia Madagascar Malawi Mali Mozambique Nepal Nicaragua Niger Nigeria Pakistan Paraguay Peru Philippines Rwanda Senegal Sierra Leone South Africa Sudan Swaziland Thailand Uganda United Republic of Tanzania Zambia Zimbabwe |
Specializations | |
|
Delivery of health services and care Technical Assistance |
Specializations in Countries | |
| Technical Assistance | Afghanistan |
| Technical Assistance | Angola |
| Technical Assistance | Benin |
| Technical Assistance | Botswana |
| Technical Assistance | Burkina Faso |
| Technical Assistance | Cote d'Ivoire |
| Technical Assistance | Equatorial Guinea |
| Technical Assistance | Ethiopia |
| Technical Assistance | Ghana |
| Technical Assistance | Guatemala |
| Technical Assistance | Guinea |
| Technical Assistance | Guyana |
| Technical Assistance | Haiti |
| Technical Assistance | India |
| Technical Assistance | Indonesia |
| Technical Assistance | Kenya |
| Technical Assistance | Lesotho |
| Technical Assistance | Liberia |
| Technical Assistance | Madagascar |
| Technical Assistance | Malawi |
| Technical Assistance | Mozambique |
| Technical Assistance | Nepal |
| Technical Assistance | Niger |
| Technical Assistance | Nigeria |
| Technical Assistance | Pakistan |
| Technical Assistance | Paraguay |
| Technical Assistance | Peru |
| Technical Assistance | Philippines |
| Technical Assistance | Rwanda |
| Technical Assistance | Sierra Leone |
| Technical Assistance | South Africa |
| Technical Assistance | Sudan |
| Technical Assistance | Swaziland |
| Technical Assistance | Thailand |
| Technical Assistance | Uganda |
| Technical Assistance | United Republic of Tanzania |
| Technical Assistance | Zambia |
| Technical Assistance | Zimbabwe |
Contribution | |
| Please tell us how your organization will contribute to the Global Plan to Stop TB by briefly describing its involvement in any of the areas of work listed below: | |
|
DOTS Expansion and Enhancement: Enhanced case finding in facilities and/or communities in Kenya, Mozambique, Tanzania, Zambia TB in pre-service education in Afghanistan, Botswana, Ghana, Lesotho, Liberia, Mozambique, South Africa Respiratory/TB infection control in several countries in sub-Saharan Africa. Drug-Resistant TB: Support the Ministry of Health in guideline development in Mozambique TB-HIV: Intensified case finding in HIV in several countries in sub-Saharan Africa. TB/HIV integration in Zambia |
|
Declaration | |
| Declaration of interests: None. | |
| Application date: | September 2, 2008 |
| Last updated: | November 8, 2011 |